Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Imaginostics logo — Innovative Diagnostic Solutions

Imaginostics

Innovative Diagnostic Solutions

Founded 2018 United States Cambridge, United States 8 employees Grant Total: $3.13M Biotechnology, Health Care

General Information

Company Name Imaginostics
Founded Year 2018
Location United States Cambridge, United States
Employees 8
Industries Biotechnology, Health Care
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Imaginostics. To contact Imaginostics, visit imaginostics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Imaginostics compare?

A PDF of Imaginostics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Imaginostics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Imaginostics

Imaginostics is a biotechnology startup based in the United States, founded in 2018. The company's slogan, "Innovative Diagnostic Solutions," aptly captures its mission. Imaginostics is dedicated to creating the next generation of precision medicine diagnostic tools, aiming to serve clinicians and drug developers to transform personalized healthcare, accelerate drug development, and combat aging. The company's proprietary MRI physics-based technology sets it apart, offering a significant advancement in diagnostic imaging. This technology promises 10X better vascular images and quantitative measurements for vascular structure, function, and leakage. Notably, the technology and software are compatible with existing MRI scanners, providing added convenience. Moreover, it is compatible with safe iron supplements for contrast, eliminating the need for gadolinium. Imaginostics' focus on providing biomarker solutions through Contract Research Organizations (CROs) to pharma, coupled with its involvement in pre-clinical and clinical research, positions the company as a key player in the healthcare and biotechnology sectors. Its collaborations with world-renowned researchers at leading institutions underscore the company's commitment to advancing medical diagnostics and research. The startup recently received a $915.93K grant investment on 15 September 2022 from the National Institute on Aging, further validating its potential and attractiveness to investors. For more information, visit www.imaginostics.com.

Business keywords: Precision Medicine, Diagnostic Tools, MRI Technology, Vascular Imaging, Quantitative Measurements, Healthcare Innovation, Drug Development, Biomarker Solutions, CRO Collaboration, Pre-clinical Research, Clinical Research, Medical Imaging, Personalized Medicine, Aging Research

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $915.93K 1
National Institute on Aging
15 Sep 2022
Seed Round $725.00K 1
Alzheimer's Drug Discovery Foundation
06 Sep 2022
Seed Round $50.00K 1
UB Ventures
UB Ventures
01 May 2022
Grant $436.56K 1
National Institute of Mental Health
National Institute of Mental Health
22 Jan 2022
Seed Round $600.00K 1
Ideaship
Ideaship
01 Jan 2021
Seed Round $400.00K -
01 Jul 2018

Imaginostics Alternatives & Competitors

View All Alternatives
Imaginostics vs
SynchroPET
SynchroPET

SynchroPet is a biotechnology firm with groundbreaking technology in the radiological PET scan field...

Non Equity Assistance
6 employees
Biotechnology, Health Care
Imaginostics vs
Polaris Biology
Polaris Biology China

Meet the next resolution in medicine

Series B
15 employees
Biopharma, Biotechnology
Imaginostics vs
Magnetic Insight, Inc
Magnetic Insight, Inc United States

Magnetic Particle Imaging - Advancing Molecular Imaging

Series B
19 employees
Biotechnology, Health Care
View all alternatives

FAQ About Imaginostics

Innovative Diagnostic Solutions
Imaginostics was founded in 2018.
Imaginostics is headquartered in Cambridge, United States.
Imaginostics operates in Biotechnology and Health Care. Its work centres on Precision Medicine, Diagnostic Tools, MRI Technology and Vascular Imaging.
Imaginostics has approximately 8 employees.
Imaginostics has completed 6 funding rounds, raising a total of $3.13M. The latest funding stage is Grant.
Top alternatives and competitors to Imaginostics include SynchroPET, Polaris Biology, Magnetic Insight, Inc, ViewRay, Inc., SuperSonic Imagine. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Imaginostics and SynchroPET are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Imaginostics, https://www.bouncewatch.com/company/imaginostics, updated 18 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout